Search

everythinglearnresearchcommunity

for

Search:↓

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

The study created a mouse model that survives longer and shows fewer symptoms of pemphigus vulgaris.

PGD2 stops hair growth and is higher in bald men with AGA.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Calcipotriol does not improve the effectiveness of squaric acid dibutylester in treating alopecia areata.

DDAIP-HCl significantly increases minoxidil absorption into the skin.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

Topical sulfonylurea may reduce excessive hair growth caused by certain medications.

0.5% TPGS boosts hair growth with minoxidil, but 2% TPGS increases minoxidil absorption.

The microneedle patch boosts hair growth by reducing DHT and oxidative stress.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Gamma-ray exposure improves genome editing efficiency in mice using the i-GONAD method.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Topical Vorinostat shows promise for treating alopecia areata by promoting hair regrowth.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Bimekizumab effectively treats scalp cellulitis and improves quality of life.

Baricitinib may cause low blood sugar in some patients, so careful monitoring is needed.

Diphencyprone therapy for hair loss can cause vitiligo.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Ginsenosides Rb₁ and Rd may help prevent hair loss by promoting hair cell growth.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.